Larimar Therapeutics | Investor Presentation Deck | 44 slides · page 13 of 44
The slide establishes a baseline for FXN levels in healthy individuals to contextualize the deficiency seen in Friedreich's Ataxia (FA) patients.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
bar-vertical bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.